Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dyphylline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.68 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dyphylline SCHEMBL123781 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL8192 | 1.00 | LMNA (1.00) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL27937456 | 0.99 | LMNA (0.97) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL28299816 | 0.95 | LMNA (0.90) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL13724353 | 0.95 | LMNA (0.90) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL5194181 | 0.95 | LMNA (0.90) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL9007973 | 0.93 | SMN1; SMN2 (0.86) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| SCHEMBL5265296 | 0.89 | LMNA (0.81) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| SCHEMBL10063431 | 0.89 | LMNA (0.80) | LMNASMN1; SMN2POLBADORA2BRXFP1 | |
| Dyphylline SCHEMBL10890402 | 0.89 | LMNA (0.78) | LMNASMN1; SMN2POLBADORA2BRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3137065-A2 | COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES | Pharnext (FR) | 2017-03-08 | — | — | EP | disclosed |
| WO-2015165948-A2 | COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES | PHARNEXT (FR) | 2015-11-05 | — | — | WO | disclosed |
| EP-2560631-A2 | BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROGICAL DISORDERS | Pharnext (FR) | 2013-02-27 | — | — | EP | disclosed |
| EP-2496226-A1 | NEW THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE | Pharnext (FR) | 2012-09-12 | — | — | EP | disclosed |
| WO-2012117076-A2 | BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROGICAL DISORDERS | PHARNEXT (FR) | 2012-09-07 | — | — | WO | disclosed |
| WO-2012117073-A2 | NEW COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | PHARNEXT (FR) | 2012-09-07 | — | — | WO | disclosed |
| WO-2011054759-A1 | NEW THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE | PHARNEXT (FR) | 2011-05-12 | — | — | WO | disclosed |